Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | Unknown | PO / MO |
The patient took three doses of Vivotif regularly and did not take the fourth dose due to temperature excursion; Case reference number US-BN-2024-002341 is a spontaneous case initially received from nurse via agency (reference number USBAV24-1960) on 13-Aug-2024 and concerns a male patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On 05-Aug-2024, the patient took the first dose of Vivotif (batch number: unknown), at unknown dose, or site of administration, orally, for unknown indication. On 07-Aug-2024, two days after the first dose, the patient took the second dose of Vivotif (batch number: unknown), at unknown dose, or site of administration, orally. On 09-Aug-2024, two days after the second dose, the patient took the third dose of Vivotif (batch number: unknown), at unknown dose, or site of administration, orally. On an unspecified date, as reported, after the third dose, Vivotif vaccine was out of the fridge for one hour, maximum temperature reached around 80-90 Fahrenheit. As reported, the patient did not receive the fourth dose of Vivotif on 11-Aug-2024 (explicitly coded as 'Inappropriate schedule of vaccine administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240813-47204c to US-BAVARIAN NORDIC A/S-US-BN-2024-002341, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A male patient did not receive his fourth dose of Vivotif, as it underwent a temperature excursion. This is considered inappropriate schedule of vaccine administered. No associated adverse events were report. Inappropriate schedule of vaccine administered is listed per company convention. Medical history was not reported. Inappropriate schedule of vaccine administered is not related to Vivotif, but to human error. The case is non-serious.; Sender's Comments: A male patient did not receive his fourth dose of Vivotif, as it underwent a temperature excursion. This is considered inappropriate schedule of vaccine administered. No associated adverse events were report. Inappropriate schedule of vaccine administered is listed per company convention. Medical history was not reported. Inappropriate schedule of vaccine administered is not related to Vivotif, but to human error. The case is non-serious. USBAV24-1960:
Comments: None